- Home
- NIVF vs ADIL Comparison
NIVF vs ADIL Comparison
Compare NIVF & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NIVF
- ADIL
- Stock Information
- Founded
- NIVF 2011
- ADIL 2010
- Country
- NIVF Hong Kong
- ADIL United States
- Employees
- NIVF N/A
- ADIL N/A
- Industry
- NIVF
- ADIL Biotechnology: Pharmaceutical Preparations
- Sector
- NIVF
- ADIL Health Care
- Exchange
- NIVF NYSE
- ADIL Nasdaq
- Market Cap
- NIVF 3.9M
- ADIL 4.3M
- IPO Year
- NIVF N/A
- ADIL 2018
- Fundamental
- Price
- NIVF $0.71
- ADIL $0.70
- Analyst Decision
- NIVF
- ADIL Strong Buy
- Analyst Count
- NIVF 0
- ADIL 1
- Target Price
- NIVF N/A
- ADIL $8.00
- AVG Volume (30 Days)
- NIVF 357.8K
- ADIL 73.2K
- Earning Date
- NIVF 01-01-0001
- ADIL 05-13-2025
- Dividend Yield
- NIVF N/A
- ADIL N/A
- EPS Growth
- NIVF N/A
- ADIL N/A
- EPS
- NIVF N/A
- ADIL N/A
- Revenue
- NIVF $5,679,218.00
- ADIL N/A
- Revenue This Year
- NIVF N/A
- ADIL N/A
- Revenue Next Year
- NIVF N/A
- ADIL N/A
- P/E Ratio
- NIVF N/A
- ADIL N/A
- Revenue Growth
- NIVF N/A
- ADIL N/A
- 52 Week Low
- NIVF $0.11
- ADIL $0.61
- 52 Week High
- NIVF $9.15
- ADIL $3.10
- Technical
- Relative Strength Index (RSI)
- NIVF 54.67
- ADIL 40.52
- Support Level
- NIVF $0.56
- ADIL $0.67
- Resistance Level
- NIVF $0.77
- ADIL $0.72
- Average True Range (ATR)
- NIVF 0.15
- ADIL 0.05
- MACD
- NIVF -0.01
- ADIL -0.00
- Stochastic Oscillator
- NIVF 75.99
- ADIL 16.67
About NIVF NEWGENIVF GROUP LIMITED
NewGenIvf Group Ltd is a company engaged in providing assisted reproductive services in Asia Pacific with a focus on providing fertility treatments to fulfil the dreams of building families, NewGenIvf mainly offers two services, namely first which is a in-vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and surrogacy and ancillary caring services.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.